Opus Point Partners Management’s Charles River Laboratories CRL Stock Holding History

Opus Point Partners Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$280K	Hold	2,112	–	–	0.51%	43
2019 Q2	$300K	Hold	2,112	–	–	0.44%	53
2019 Q1	$307K	Sell	2,112 -553	-21%	-$72.7K	0.42%	60
2018 Q4	$302K	Sell	2,665 -161	-6%	-$20.2K	0.66%	27
2018 Q3	$380K	Buy	2,826 +92	+3%	+$11.4K	0.91%	36
2018 Q2	$307K	Buy	2,734 +121	+5%	+$13.1K	0.67%	34
2018 Q1	$279K	Buy	2,613 +459	+21%	+$49.5K	0.55%	41
2017 Q4	$236K	Sell	2,154 -2,801	-57%	-$305K	0.2%	54
2017 Q3	$535K	Buy	4,955 +2,393	+93%	+$246K	0.48%	46
2017 Q2	$259K	Sell	2,562 -1,879	-42%	-$173K	0.24%	55
2017 Q1	$399K	Buy	4,441 +1,138	+34%	+$96.7K	0.3%	49
2016 Q4	$252K	Buy	+3,303	New	+$251K	0.2%	48

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Opus Point Partners Management's CRL Position: Q3 2019 in Review

Opus Point Partners Management held its Charles River Laboratories (CRL) position steady in Q3 2019 at 2,112 shares worth $280K. The position accounts for 0.51% of the portfolio, ranked #43.

Opus Point Partners Management first reported a position in CRL in Q4 2016 and has held it in 12 quarters since. The position peaked at $535K in Q3 2017. 396 funds tracked by Wall St. Rank hold CRL as of Q3 2019.

Opus Point Partners Management held 2,112 shares of Charles River Laboratories worth $280K as of Q3 2019.
Opus Point Partners Management left its Charles River Laboratories share count unchanged in Q3 2019.
Charles River Laboratories made up 0.51% of Opus Point Partners Management's portfolio in Q3 2019, its #43 holding.
Opus Point Partners Management first reported a position in Charles River Laboratories in Q4 2016 and has held it in 12 quarters since.
Opus Point Partners Management's Charles River Laboratories position peaked at $535K in Q3 2017.
396 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.